C ellular decisions result from signaling events mediated by the extracellular matrix, cell-cell interactions, and soluble factors. These extrinsic cues contain chemical entities that can promote cell adhesion or signaling. The fields of surface and materials science are yielding strategies to control the presentation of cell adhesive compounds (1, 2) . Because of their stability relative to proteins, the preferred compounds for surface conjugation are small molecules, carbohydrates, and peptides. For example, the discovery of the cell adhesive peptide RGD (3) has enabled major advances in tissue engineering (4). A complementary level of control over signaling has been difficult to achieve. Some of the barriers are due to the intrinsic attributes of the signaling molecules themselves. Specifically, signals such as growth factors are diffusible; therefore, it is difficult to harness their activities at a specific site. Indeed, their spatial presentation in vivo is strictly regulated. For instance, a reservoir of growth factors can be generated by their local secretion and storage in latent form in the extracellular matrix (5) . We envisioned that fully synthetic surfaces could be developed that control the location and extent of growth factor activation. The resulting substrate would have the properties required for constructing synthetic cell niches.
We focused on TGF-β because of its important and myriad roles in tissue homeostasis. TGF-β controls cell proliferation, differentiation, adhesion, migration, apoptosis, and extracellular matrix deposition (6, 7) . TGF-β signaling is initiated when the growth factor binds and mediates the assembly and activation of a cell-surface receptor complex composed of the type I and II TGF-β receptors (TβRI and TβRII) (Fig. S1) (8, 9) . The activated TβRI kinase catalyzes the phosphorylation of the proteins Smad2 and Smad3 (Smad2/3). The phosphorylated Smad2/3 associate with Smad4, resulting in their translocation into the nucleus to regulate gene expression. Depending upon context, the activation of this signaling cascade has either essential or deleterious consequences. Thus, methods that harness its beneficial roles would be valuable to the fields of tissue engineering and regenerative medicine.
Our strategy was devised to use low levels of endogenous active TGF-β [approximately 1 pM in human serum (10) ] to exploit and control signaling. We were inspired by a key attribute of TGF-β signaling: the high potency of TGF-β. The growth factor binds tightly to its cell-surface receptors with measured dissociation constants (K d ) for binding cells ranging from 5 to 30 pM (6). This tight binding depends on avidity (Fig. 1 A-C) . On the cell surface, TβRI and TβRII exist as noncovalent homodimers or homoligomers, and this organization can promote TGF-β complexation. We hypothesized that preorganization of the receptor complex could further augment the avid TGF-β binding because the transmembrane signaling components would be poised to form an active signaling complex (Fig. 1D) .
The term "preorganization" was introduced by Cram to describe how interactions are highly favorable when two interacting molecules possess a "complementarity of binding site placement in host and guest" (11) . We envisioned that the concept of preorganization could be extended from simple complexes to macromolecular assemblies. Specifically, if receptors could be preclustered, they would be poised for activation by the endogenous TGF-β, and the local concentration threshold for TGF-β signal activation lowered. For this approach to be successful, the receptor complexes do not have to be oriented precisely because receptors clustered locally would still exhibit a decrease in translational entropy. Such a scenario favors the binding of TGF-β to receptors that are poised for signal transduction. Our strategy to preorganize the canonical TGF-β signaling complex was to generate a surface displaying ligands that bind both TβRs but do not interfere with TGF-β complexation or signaling (Fig. 1E) . Previously, we identified two peptide ligands LTGKNFPMFHRN (Pep1) and MHRMPSFLPTTL (Pep2) that interact with both TβRI-ED and TβRII-ED (K d ∼ 10 −5 M) (12) . When Pep1 is displayed on a dendrimer, the resulting multivalent ligand exhibits high functional affinity for both TβRs. In addition, we found that neither Pep1 nor Pep2 can compete with TGF-β for the TβRII extracellular domain, nor do these peptides influence TGF-β signaling (12) . These observations indicate that the peptides occupy a binding site on the receptors that is distinct from that used by TGF-β. Accordingly, we reasoned that a tailored surface presenting these peptide ligands would sensitize cells to TGF-β signaling.
Results and Discussion
Fabrication of Synthetic Surfaces Presenting TβR-Binding Peptides.
To generate a surface display of peptides, we employed selfassembled monolayers (SAMs) of peptide-conjugated alkanethiols (ATs) on gold (4, (13) (14) (15) (16) . ATs form defined assemblies and therefore should give rise to reproducible biological activity. Thus, the peptide-substituted ATs were synthesized (14) and used to fabricate SAMs in an array format (13) . The ability of these tailored surfaces to support the adhesion of cells expressing the TGF-β receptors was evaluated. We tested the cell line NMuMG, a mouse mammary gland cell line that produces both TβRs and responds to the growth factor. The cells adhered to SAMs displaying either Pep1 or Pep2, but not to peptide-free surfaces (Fig. S2 ). Even surfaces displaying the peptide at low densities (approximately 4%) supported adhesion.
Synthetic Surfaces Sensitize Cells to Endogenous TGF-β. The ability of synthetic surfaces presenting specific TβR-binding peptides to promote TGF-β signaling was evaluated. A hallmark of TGF-β signaling is the translocation of Smad2/3 from the cytosol to the nucleus. We therefore monitored Smad2/3 localization by immunostaining of NMuMG cells grown on either Pep1-functionalized or control surfaces. When cells grown atop plastic tissue culture plates were exposed to TGF-β1, Smad2/3 was found in the nucleus. This change in localization depended on the dose of TGF-β with a saturating concentration of 100 pM (Fig. S3 ). When cells were grown on Pep1-or Pep2-functionalized surfaces for 48 h in their normal growth medium without supplemental TGF-β, Smad2/3 also migrated to the nucleus (Fig. 2B ). The extent of this accumulation was comparable to that observed in cells grown in the medium supplemented with 100 pM TGF-β. The Smad2/3 translocalization was inhibited by a TβRI kinase inhibitor [SB-431542 (17, 18) ], indicating that Pep1 and Pep2-functionalized surfaces act through the TβRI kinase ( Fig. 2 A and C) .
Given that our synthetic surfaces activate Smad2/3 nuclear translocation, we evaluated the importance of endogenous TGF-β in the culture system. We immunodepleted TGF-β using a neutralizing antibody that recognizes most isoforms. Smad3 nuclear translocation results in transcription of the genes PAI-1 and Snail; therefore, the expression levels of these genes were monitored. Cells cultured for 2-3 d on the Pep1-functionalized surface in the growth medium up-regulated PAI-1 and Snail expression (Fig. 3 A-C) . The extent of activation is similar to that observed in cells cultured on plastic plates in the presence of 100 pM TGF-β. Treatment with the TGF-β neutralizing antibody, however, eliminated signaling under either condition. These results indicate that the activity of Pep1 surfaces depends on endogenous TGF-β but does not require the addition of exogenous TGF-β.
Our model predicted that the observed effects were due to sensitization of the cells to minute quantities of TGF-β, but we examined alternative explanations. The surfaces do not act by up-regulating TGF-β expression, as mRNA levels of TGF-β isoforms do not increase (Fig. 3 D and E) . To test whether signaling results from a generic effect of the peptide-functionalized surface, we used a SAM presenting a control peptide (VHBD) that can bind to glycosaminoglycans on the cell but should not interact with TβRs (19) . As expected, VHBD peptide-functionalized SAMs did not promote PAI-1 expression (Fig. 3F) . To ascertain whether activation of TGF-β signaling by Pep1 is unique to NMuMG cells, we examined an alternative TGF-β-responsive cell line (A549). As with NMuMG cells, A549 cells cultured on the Pep1-functionalized surface were sensitized to TGF-β signaling (Fig. 4 A and B) . We then explored the possibility that signaling results from insufficient cellular adhesion. We synthesized a mixed surface presenting both Pep1 and VHBD peptides that supports excellent cellular adhesion and spreading (19) . This mixed surface also sensitizes cells to TGF-β (Fig. 4 C-E) . Moreover, this cellular response did not depend on the surface density of the strongly adhesive VHBD peptides, indicating that the observed activation is unaffected by differences in cell adhesion strength. To investigate further whether Pep1 surfaces potentiate TGF-β signaling, we treated surface-bound cells with low doses of TGF-β (Fig. 4F) . As expected, the responses of cells grown on Pep1 presenting surfaces to 1 pM TGF-β1 were augmented significantly relative to those cultured on VHBD peptide-functionalized surfaces alone. Together, the results indicate that Pep1-functonalized surfaces greatly amplify cell signaling induced by endogenous TGF-β.
Synthetic Surfaces Induce Cell Growth Arrest and Promote the Epithelial-Mesenchymal Transition. A hallmark of TGF-β signaling in epithelial cells is growth arrest at the G1 phase of the cell cycle (20, 21) . To test if the synthetic surfaces can induce this effect, cells were cultured in a TGF-β1-supplemented medium or upon the synthetic surfaces for 24 h in their normal growth medium. The cell population at each phase was quantified by DNA staining (Fig. S4) . In analogy to results obtained with soluble TGF-β, cells on the Pep1-or Pep2-functionalized surfaces were inhibited from entering S phase.
The ability of the synthetic surfaces to activate signaling prompted us to assess whether they could induce a cell-fate decision: the epithelial-mesenchymal transition (EMT) (22) (23) (24) . Intriguingly, NMuMG cells cultured on Pep1-or Pep2-functionalized surfaces for 48-54 h lost polarity and adopted a mesenchymal morphology (Fig. 5A) . After 5 d, cells grown on the synthetic surfaces no longer displayed E cadherin, a marker for epithelial cells (Fig. 5B) . To determine whether the ability of the surfaces to induce morphology changes depends upon TGF-β signaling, we used the TβRI kinase inhibitor SB-431542. This compound blocked EMT. Peptide-functionalized surfaces also promoted the up-regulation of alpha-smooth muscle actin (α-SMA), a mesenchymal marker (Fig. 5 C and D) . In addition, the cytoplasmic/nuclear localization of β-catenin is consistent with that in mesenchymal cells (Fig. S5) . We then tested whether the synthetic surfaces nonspecifically sensitize cells to endogenous bone morphogenetic protein (BMP), a TGF-β superfamily member. This experiment also examines the specificity of activation because Pep1 does not bind to BMP receptors (12) . A mouse myoblast cell line (C2C12), which responds to BMP signaling by differentiating into alkaline phosphatase-positive osteoblasts (Fig. S6) , was plated onto the surfaces. As expected, Pep1-functionalized surfaces did not induce BMP-4-regulated C2C12 cell differentiation. Together, the data indicate that the synthetic surfaces can induce a cell-fate decision by selectively potentiating TGF-β signaling.
Synthetic Surfaces Specifically Activate TGF-β Regulated Genes. We employed a DNA microarray to evaluate the scope and specificity of surface-regulated gene expression. A comparison of untreated NMuMG cells versus those grown atop Pep1-functionalized surfaces revealed 2,135 genes that changed their expression levels by greater than 4-fold (Fig. 6A) . The gene expression profiles of cells treated with TGF-β and those grown on the synthetic surface were similar. These findings add to the evidence that the synthetic surfaces mediate TGF-β signaling. The expression levels of approximately 600 genes were altered (>4-fold) by TGF-β treatment but not by the synthetic surfaces (Fig. 6B) . Accordingly, this group of genes likely has a higher threshold for activation or suppression.
Spatial Control over Cell-Fate Decision Made Possible by Synthetic
Surfaces. The ability of Pep1-and Pep2-modified surfaces to promote EMT suggests that they can be used for spatial control of cell differentiation. We therefore patterned a surface such that the left side was bare glass and the right was modified with a peptide-substituted SAM (Fig. S7) . We anticipated that the glass surface would adsorb proteins from the serum and thereby support epithelial cell proliferation, whereas the peptide-substituted section should induce TGF-β-dependent differentiation. NMuMG cells were grown on the composite surface for 2 d. Staining for α-SMA revealed distinct populations of cells on the different regions: Cells attached and self-renewed on the glass, but underwent EMT on Pep1-functionalized surfaces (Fig. 5E ). This spatial control over cell fate is a key attribute of endogenous niches. In parallel to our efforts focused on activating specific ligand-receptor recognition and cell signaling, surface chemistry strategies have recently been developed to fine-tune stem cell fate by nanopatterning nonspecific adhesive moieties (25) . We envision that these distinct approaches can be integrated to maximize control over stem cell fate and thereby advance the field of tissue engineering.
Conclusions
Our results demonstrate that chemically defined surfaces can control signaling pathways that result in cell-fate decisions. Besides their functional activity, the tailored surfaces possess several propitious features. First, their stability and ease of modification can facilitate applications in tissue engineering and regenerative medicine. Second, spatial control over cell fate, which is a prerequisite for building synthetic niches, can be achieved by surface patterning. Last, because the synthetic surfaces work by amplifying the signal induced by the natural growth factor, our approach exploits endogenous mechanisms for regulating gene expression, secretion, storage, and activation. Many other growth factors elicit signaling through the formation of homodimeric (26) [e.g., FGF (27) , EGF (28) , and VEGF (29)] or heterodimeric receptor complexes [e.g., BMP and Wnt (30, 31) ]. Thus, the preorganization strategy to controlling growth factor activity is one that is general. Moreover, by using a protein-binding site distinct from that employed by the signal itself, even growth factors that require endocytosis for signaling can be sensitized. Thus, we anticipate that multivalent scaffolds can serve as general platforms to nucleate the assembly of higher order signaling complexes and thereby amplify specific growth factor signals.
Materials and Methods
Fabrication of Pep-AT SAM. A linker for solid-supported synthesis of tailored ATs was assembled and loaded onto resin as described previously (14) . Pep1 and Pep2 were built onto AT resin by using Fmoc solid-phase peptide synthesis. The resulting protected peptides were liberated from the resin with simultaneous protecting group release, and Pep1-AT and Pep2-AT were purified by HPLC. For fabrication of the surfaces, Pep1-AT, Pep2-AT, and Glucamine-AT (13) were each dissolved in ethanol [1 mM concentration, with 5 mM tris(2-carboxyethyl) phosphine to keep thiol reduced]. Gold-coated glass slides (250 Å gold, 10 Å chromium coated slides, 22 mm square, 0.16 mm thick) were purchased from EMF Corporation. The solvophobic and cytophobic perfluoro-AT SAM was used as the background (13) . The SAM array displaying Pep-AT SAM was prepared by spotting solutions with different ratios of Pep-AT and glucamine-AT onto the bare gold "holes" generated by photolithography. Larger chips presenting a single Pep-AT/ glucamine SAM were fabricated by sandwiching droplets of mixed solutions containing Pep-AT and glucamine-AT between two gold-coated slides. SAMs were allowed to form in humidity chambers for 24 h before use.
Cell Lines and Cell Culture Conditions. NMuMG, A549, and C2C12 cells were purchased from American Type Culture Collection (CRL-1636). NMuMG cells were cultured in DMEM supplemented with 10% FBS, 50 units∕mL penicillin, 50 μg∕mL streptomycin, and 10 μg∕mL bovine or human insulin. A549 cells and C 2 C 12 cells were cultured in DMEM supplemented with 10% FBS, 50 units∕mL penicillin, and 50 μg∕mL streptomycin. per gene were used. Normalized data was analyzed by Arraystar v2.0 and heatmaps were generated.
